3'-DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
3-脱氧核苷类似物作为潜在的抗病毒剂
基本信息
- 批准号:3144251
- 负责人:
- 金额:$ 12.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-03-01 至 1993-02-28
- 项目状态:已结题
- 来源:
- 关键词:2'3' dideoxynucleoside antiAIDS agent antiviral agents azacitidine chemical structure function cytomegalovirus cytosine cytosine arabinoside cytotoxicity drug adverse effect drug design /synthesis /production drug metabolism drug screening /evaluation human immunodeficiency virus mass spectrometry nuclear magnetic resonance spectroscopy nucleoside analog nucleoside triphosphate tissue /cell culture
项目摘要
This investigation has as its goal the design and synthesis of a series of
3'-deoxy pyrimidine and purine nucleoside analogs, and some of their
nucleotide addition, the 2', 3'-unsaturated, 2', 3'-dideoxy-ara-C
derivatives of 3-deazacytidine will be synthesized and evaluated as
potential anti-HIV and anti-CMV agents. The approaches to be employed
include the development of methodology mass spectrum, and other
spectroscopic techniques, and the determination of their biological and
biochemical effects.
Recently, a lead compound, 1-(3-deoxy-B-D-threopentofuranosyl) cytosine
(3'-deoxy-ara-C), has been synthesized and evaluated for its antiviral
activity in this laboratory. Our preliminary studies have shown that 3'-
deoxy-ara-C not only has potent anti-HCMV activity (ED50 = 0.31 ug/mL vs
ED50 = 0.92 ug/mL for DHPG), but also is structurally different from DHPG.
Based on these findings, the 5'-mono- and triphosphates of 3'-deoxy-ara-C
will be prepared for biochemical studies. The understanding of the
mechanism of action of 3'-deoxy-ara-C may lead to the design and synthesis
of new antiviral agents with a better therapeutic index.
本研究的目标是设计和合成一系列的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAI-SHUN LIN其他文献
TAI-SHUN LIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAI-SHUN LIN', 18)}}的其他基金
3'-DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
3-脱氧核苷类似物作为潜在的抗病毒剂
- 批准号:
3144252 - 财政年份:1990
- 资助金额:
$ 12.54万 - 项目类别:
DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
脱氧核苷类似物作为潜在的抗病毒剂
- 批准号:
3144250 - 财政年份:1990
- 资助金额:
$ 12.54万 - 项目类别:
3'-DEOXYNUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
3-脱氧核苷类似物作为潜在的抗病毒剂
- 批准号:
3144249 - 财政年份:1990
- 资助金额:
$ 12.54万 - 项目类别:
DEOXY NUCLEOSIDE ANALOGS AS POTENTIAL ANTIVIRAL AGENTS
脱氧核苷类似物作为潜在的抗病毒剂
- 批准号:
2064982 - 财政年份:1990
- 资助金额:
$ 12.54万 - 项目类别:
NOVEL NUCLEOSIDES AS ANTICANCER AND ANTIVIRAL AGENTS
作为抗癌剂和抗病毒剂的新型核苷
- 批准号:
3188511 - 财政年份:1987
- 资助金额:
$ 12.54万 - 项目类别:
NOVEL NUCLEOSIDES AS ANTICANCER AND ANTIVIRAL AGENTS
作为抗癌剂和抗病毒剂的新型核苷
- 批准号:
3188510 - 财政年份:1987
- 资助金额:
$ 12.54万 - 项目类别:
NOVEL NUCLEOSIDES AS ANTICANCER AND ANTIVIRAL AGENTS
作为抗癌剂和抗病毒剂的新型核苷
- 批准号:
3188507 - 财政年份:1987
- 资助金额:
$ 12.54万 - 项目类别:
相似海外基金
ACTG 303--RISK STATUS FOR DISEASE PROGRESSION AND RESPONSE TO ANTIAIDS AGENT
ACTG 303--疾病进展的风险状态和抗艾滋病药物的反应
- 批准号:
6114298 - 财政年份:1998
- 资助金额:
$ 12.54万 - 项目类别:
ACTG 303--RISK STATUS FOR DISEASE PROGRESSION AND RESPONSE TO ANTIAIDS AGENT
ACTG 303--疾病进展的风险状态和抗艾滋病药物的反应
- 批准号:
6275533 - 财政年份:1997
- 资助金额:
$ 12.54万 - 项目类别: